Caspase-cleaved actin (fractin) immunolabelling of Hirano bodies

Neuropathology and Applied Neurobiology

Volumn 26, Issue 4, 2000, Pages 342-346

  Rossiter, J P ^a   Anderson, L L ^a   Yang, F ^b   Cole, G M ^b  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Actins; Alzheimer's disease; Caspases; Hippocampus; Hirano bodies; Immunohistochemistry

Indexed keywords

ACTIN; ACTIN BINDING PROTEIN; AMINO ACID; ASPARTIC ACID; CASPASE; POLYCLONAL ANTIBODY; RABBIT ANTISERUM;

AGING; ALZHEIMER DISEASE; ANTIBODY LABELING; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL INCLUSION; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVITY; EOSINOPHIL; HIPPOCAMPUS; HIRANO BODY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; PERIKARYON; PRIORITY JOURNAL;

ACTINS; ALZHEIMER DISEASE; ANTIBODIES; BRAIN STEM; CASPASE 3; CASPASES; HIPPOCAMPUS; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; IMMUNE SERA; IMMUNOHISTOCHEMISTRY; INCLUSION BODIES; PEPTIDE FRAGMENTS;

EID: 0033861741     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2990.2000.00252.x     Document Type: Article

References (39)

1. 1 Callahan LM, Vaules WA, Coleman PD. Quantitative decrease in synaptophysin message expression and increase in cathepsin D message expression in Alzheimer disease neurons containing neurofibrillary tangles. J Neuropathol Exp Neurol 1999; 58: 275-87
2. 2 Cataldo AM, Barnett JL, Berman SA et al. Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: evidence for early up-regulation of the endosomal-lysosomal system. Neuron 1995; 14: 671-80
3. 3 Cattoretti G, Pileri S, Parravicini C et al. Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J Pathol 1993; 171: 83-98
4. 4 Cohen GM. Caspases: the executioners of apoptosis. Biochem J 1997; 326: 1-16
5. 5 Deiss LP, Galinka H, Berissi H, Cohen O, Kimchi A. Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha. EMBO J 1996; 15: 3861-70
6. 6 Galloway PG, Perry G, Gambetti P. Hirano body filaments contain actin and actin-associated proteins. J Neuropathol Exp Neurol 1987; 46: 185-99
7. 7 Galloway PG, Perry G, Kosik KS, Gambetti P. Hirano bodies contain tau protein. Brain Res 1987; 403: 337-40
8. 8 Gervais FG, Xu D, Robertson GS et al. Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation. Cell 1999; 97: 395-406
9. 9 Goldman JE. The association of actin with Hirano bodies. J Neuropathol Exp Neurol 1983; 42: 146-52
10. 10 Hirano A. Hirano bodies and related neuronal inclusions. Neuropathol Appl Neurobiol 1994; 20: 3-11
11. 11 Ivins KJ, Bui ET, Cotman CW. Beta-amyloid induces local neurite degeneration in cultured hippocampal neurons: evidence for neuritic apoptosis. Neurobiol Dis 1998; 5: 365-78
12. 12 Izumiyama N, Ohtsubo K, Tachikawa T, Nakamura H. Elucidation of three-dimensional ultrastructure of Hirano bodies by the quick-freeze, deep-etch and replica method. Acta Neuropathol (Berl) 1991; 81: 248-54
13. 13 Jordan-Sciutto K, Dragich J, Walcott D, Bowser R. The presence of FAC1 protein in Hirano bodies. Neuropathol Appl Neurobiol 1998; 24: 359-66
14. 14 Kayalar C, Ord T, Testa MP, Zhong LT, Bredesen DE. Cleavage of actin by interleukin 1 beta-converting enzyme to reverse DNAse i inhibition. Proc Natl Acad Sci USA 1996; 93: 2234-8
15. 15 Laas R, Hagel C. Hirano bodies and chronic alcoholism. Neuropathol Appl Neurobiol 1994; 20: 12-21
16. 16 LeBlanc A. Detection of actin cleavage in Alzheimer's disease. Am J Pathol 1998; 152: 329-32
17. 17 Levy-Strumpf N, Kimchi A. Death associated proteins (DAPs): from gene identification to the analysis of their apoptotic and tumor suppressive functions. Oncogene 1998; 17: 3331-40
18. 18 Mashima T, Naito M, Noguchi K, Miller DK, Nicholson DW, Tsuruo T. Actin cleavage by cpp-32/apopain during the development of apoptosis. Oncogene 1997; 14: 1007-12
19. 19 Mashima T, Naito M, Tsuruo T. Caspase-mediated cleavage of cytoskeletal actin plays a positive role in the process of morphological apoptosis. Oncogene 1999; 18: 2423-30
20. 20 Matsukawa N, Tooyama I, Kimura H et al. Increased expression of hippocampal cholinergic neurostimulating peptide-related components and their messenger RNAs in the hippocampus of aged senescence-accelerated mice. Neuroscience 1999; 88: 79-92
21. 21 Mattson MP, Partin J, Begley JG. Amyloid beta-peptide induces apoptosis-related events in synapses and dendrites. Brain Res 1998; 807: 167-76
22. 22 Mitake S, Ojika K, Katada E, Otsuka Y, Matsukawa N, Fujimori O. Accumulation of hippocampal cholinergic neurostimulating peptide (HCNP)-related components in Hirano bodies. Neuropathol Appl Neurobiol 1995; 21: 35-40
23. 23 Munch G, Cunningham AM, Riederer P, Braak E. Advanced glycation endproducts are associated with Hirano bodies in Alzheimer's disease. Brain Res 1998; 796: 307-10
24. 24 Munoz DG, Wang D, Greenberg BD. Hirano bodies accumulate c-terminal sequences of beta-amyloid precursor protein (beta-APP) epitopes. J Neuropathol Exper Neurol 1993; 52: 14-21
25. 25 Ogata J, Budzilovich GN, Cravioto H. A study of rod-like structures (Hirano bodies) in 240 normal and pathological brains. Acta Neuropathol (Berl) 1972; 21: 61-7
26. 26 Ohsawa Y, Isahara K, Kanamori S et al. An ultrastructural and immunohistochemical study of PC12 cells during apoptosis induced by serum deprivation with special reference to autophagy and lysosomal cathepsins. Arch Histol Cytol 1998; 61: 395-403
27. 27 Peterson C, Kress Y, Vallee R, Goldman JE. High molecular weight microtubule-associated proteins bind to actin lattices (Hirano bodies). Acta Neuropathol (Berl) 1988; 77: 168-74
28. 28 Porter AG, Janicke RU. Emerging roles of caspase-3 in apoptosis. Cell Death Differ 1999; 6: 99-104
29. 29 Roberts LR, Adjei PN, Gores GJ. Cathepsins as effector proteases in hepatocyte apoptosis. Cell Biochem Biophys 1999; 30: 71-88
30. 30 Rossiter JP, Anderson LL, Yang F, Cole GM. Caspase-cleaved actin (fractin) immunolabelling of apoptotic neurons in acute perinatal hypoxic-ischemic brain injury. C J Neurol Sci 1998; 25: 338-9
31. 31 Rossiter JP, Anderson LL, Yang F, Cole GM. Caspase-cleaved actin (fractin) immunolabelling of Hirano bodies. J Neuropathol Exp Neurol 1999; 58: 529
32. 32 Rossiter JP, Vanderluit JL, Anderson LL, Yang F, Cole GM, Tetzlaff W. Caspase-cleaved actin (fractin) immunoreactivity of the cytoplasm and axons of apoptotic rat facial motoneurons. Soc Neurosci Abstracts 1998; 24: 707-15
33. 33 Schmidt ML, Lee VM, Trojanowski JQ. Analysis of epitopes shared by Hirano bodies and neurofilament proteins in normal and alzheimer's disease hippocampus. Lab Invest 1989; 60: 513-22
34. 34 Schochet Ss Jr, McCormick WF. Ultrastructure of Hirano bodies. Acta Neuropathol (Berl) 1972; 21: 50-60
35. 35 Srinivasan A, Roth KA, Sayers RO et al. In situ immunodetection of activated caspase-3 in apoptotic neurons in the developing nervous system. Cell Death Differ 1998; 5: 1004-16
36. 36 Suurmeijer AJ, van der Wijk J, van Veldhuisen DJ, Yang F, Cole GM. Fractin immunostaining for the detection of apoptotic cells and apoptotic bodies in formalin-fixed and paraffin-embedded tissue. Lab Invest 1999; 79: 619-20
37. 37 Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998; 281: 1312-6
38. 38 Tomonaga M. Ultrastructure of Hirano bodies. Acta Neuropathol (Berl) 1974; 28: 365-6
39. 39 Yang F, Sun X, Beech W et al. Antibody to caspase-cleaved actin detects apoptosis in differentiated neuroblastoma and plaque-associated neurons and microglia in Alzheimer's disease. Am J Pathol 1998; 152: 379-89